Filing Details
- Accession Number:
- 0001144204-13-051490
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-18 21:30:20
- Reporting Period:
- 2013-09-16
- Filing Date:
- 2013-09-18
- Accepted Time:
- 2013-09-18 21:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559570 | David Shapiro | C/O Intercept Pharmaceuticals, Inc. 18 Desbrosses Street New York NY 10013 | Cmo & Evp - Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-16 | 3,750 | $10.40 | 9,282 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-16 | 5,016 | $49.20 | 4,266 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | Disposition | 2013-09-16 | 3,750 | $0.00 | 3,750 | $10.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 64,038 | 2018-04-01 | No | 4 | M | Direct |
Footnotes
- The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 20, 2013.
- All shares underlying this option have vested.
- This transaction was executed in multiple trades at prices ranging from $49.18 to $49.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Balance reflects certain transactions previously reported on the Form 4 filed by the reporting person on May 9, 2013 (3,000 shares of common stock underlying restricted stock units granted to the reporting person on May 7, 2013), which were previously unintentionally omitted.
Billionaire Hedge Funds
